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Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489S70had a majority of ARGS fragments (70, 61 and 77%, respectively), while
the reference and the JIA groups had high proportion of CS2-G3 frag-
ments (53 and 52%, respectively). Estimates of the relative mol-mol
proportions of the pathological aggrecanase cleavage in the IGD gen-
erating ARGS-fragment and the aggrecanase turnover cut in the CS2
region generating CS2-G3 fragments showed that the ARGS proportion
was 27% for the reference group while it was between 69 and 82% in the
adult and juvenile injury groups and in OA group. A similar comparison
of MMP generated FFGV (a cut in the IGD of aggrecan) and the aggre-
canase generated ARGS fragments showed that the FFGV fragments
amounted to 32% for the reference group while the proportion was
much lower for the adult injury (2.1%), juvenile injury (7.3%) and the OA
(1.2%) groups.Fig 1. Proportion (mol/mol) of full length aggrecan (G1-G3), aggrecanase
generated ARGS and CS2-G3 fragments, MMP generated FFGV fragments
and calpain generated IGD-PGVA fragments found in synovial ﬂuid pools
of different patient Groups.Conclusions: The OA, juvenile and adult knee injury groups show
similar aggrecan fragmentation patterns, which differ from the frag-
mentation pattern of JIA and knee healthy reference groups. This sug-
gests that the aggrecan fragmentation patterns are different between
different joint diseases. This information supports further under-
standing of mechanisms of cartilage damage in these conditions, and
may aid to distinguish different patient groups.
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RELATIONSHIP BETWEEN CONCOMITANT INJURIES SUSTAINED
DURING ACL RUPTURE AND BIOLOGICAL MARKERS OF ARTICULAR
CARTILAGE METABOLISM
S.M. Wasilko y, T.W. Tourville y, M.J. DeSarno y, J.R. Slauterbeck y,
R.J. Johnson y, A. Struglics z, B.D. Beynnon y. yUniv. of Vermont Coll. of
Med., Burlington, VT, USA; z Lund Univ., Dept. of Orthopaedics, Clinical
Sci., Lund, Sweden
Purpose: There is limited information regarding the onset and earliest
stages of post-traumatic osteoarthritis (OA), which is commonly asso-
ciated with rupture of the anterior cruciate ligament (ACL). Con-
sequently, the purpose of this investigation was to examine
relationships between concomitant injuries to the tibiofemoral articu-
lar cartilage sustained during acute ACL injury with patient-oriented
outcomes as well as biochemical markers of type II collagenmetabolism
and aggrecan degradation, compared to healthy, matched controls.
Methods: Thirty-nine ACL-reconstructed (20 women) and 32 knee
healthy control (18women) subjectsmatched for age, sex, race, BMI, and
activity level were evaluated in this cross-sectional study. Inclusion
criteria for injured subjects was: age 14-55yrs, BMI between 18.5-30,
Tegner activity score  5, no previous knee pathologies, normal ana-
tomic tibiofemoral alignment, < 2/3 meniscectomy performed at sur-
gery, and  grade 3A articular cartilage lesions (based on International
Cartilage Repair Society [ICRS] classiﬁcation). Similar inclusion criteria
were utilized for controls with the exception of: no history of knee pain
or dysfunction, normal clinical knee examination, and no abnormalitieson MRI. Articular cartilage lesions were identiﬁed under direct arthro-
scopic visualization at the time of ACL reconstruction and were docu-
mented by one of two sports medicine fellowship-trained orthopaedic
surgeons. Injured subjects were classiﬁed as low-risk for future OA
development if they displayed  grade 2 articular cartilage lesions.
Injured subjectswere classiﬁed as high-risk for futureOAdevelopment if
they displayed grade 3A articular cartilage lesions. Synovial ﬂuid sam-
ples were obtained from injured subjects immediately prior to surgery,
and from controls at a single time point. The mean interval between
index injury and surgery date was 70.1 days; range: 18-155 days. Syno-
vial ﬂuid markers of type II collagen synthesis were evaluated by
measuring concentrations of procollagen II C-propeptide (CPII) with
ELISA (Ibex).Markers of type II collagen degradationwere also evaluated
with ELISA and included collagen type II cleavage product (C2C; Ibex)
and collagen type I and II cleavage product (C1,2C; Ibex). Additionally,
the Alanine-Arginine-Glycine-Serine (ARGS) neoepitope was measured
as amarkerof aggrecandegradationusing an electrochemiluminescence
in-house immunoassay. Patient oriented outcomeswere evaluated in all
subjects with the Knee Injury and Osteoarthritis Outcome Score (KOOS).
Analysis of Variance was performed for statistical evaluation.
Results: Of the 39 ACL reconstructed individuals, 29 (74%) had articular
cartilage injuries that were grade 2 or less, while 10 (26%) had grade 3A
articular cartilage injuries. Controlling for sex, BMI, activity level, and
time between injury and baseline measurements, there were no sig-
niﬁcant differences in mean levels of markers of type II collagen
metabolism or aggrecan breakdown (p ¼ 0.48 and p ¼ 0.55, respec-
tively) between risk groups. Associations between ARGS concentration
and KOOS subscales of symptoms and pain were found to be sig-
niﬁcantly different between groups (p ¼ 0.03 and p ¼ 0.01, respec-
tively). These signiﬁcant interactions were driven by positively
correlated associations between KOOS scores and ARGS concentration
for the high risk group, and negatively correlated associations between
KOOS scores and ARGS concentration for the low risk group.
Conclusions: In ACL injured subjects with concomitant grade 3A
articular cartilage injuries, levels of synovial ﬂuid ARGS were directly
associated with improvements in KOOS symptoms and pain. As a sec-
ondary analysis of a longitudinal investigation, this study provides
preliminary, hypothesis generating data and may not be adequately
powered to elucidate true differences in biomarker concentrations
between these groups. Nevertheless, our statistically signiﬁcant ﬁnd-
ings may suggest the involvement of synovial ﬂuid ARGS in a localized
tissue repair response involving an increase in the synthesis of aggrecan
following traumatic knee injury.
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CARTILAGE COLLAGEN NEOEPITOPE C2C AND CLINICAL
PARAMETERS IN MIDDLE-AGED PATIENTS WITH KNEE PROBLEMS.
CORRELATIONS OF URINARY OUTPUT OF C2C WITH CARTILAGE
LESIONS, KOOS VALUES AND FUNCTIONAL ABILITIES OF LOWER
LIMB
A.O. Tamm y, J. Kumm y, A. Tamm y, M. Lintrop y, A. Kukner y, T. Saluse z,
L. Rips z, T. Tein z, A. Pintsaar z, A. Kukner z. yUniv. of Tartu, Tartu, Estonia;
z Tartu Univ. Hosp., Tartu, Estonia
Purpose: Intensive research in the last decade has demonstrated that
protein biomarkers are required for different purposes in early osteo-
arthritis (OA): to detect OA, to prognose its progression, to assess efﬁcacy
of intervention, etc. Although several biomarkers have acquired deﬁnite
position in the ﬁeld, none of the biomarkers applied up to now can sufﬁ-
ciently discriminate individual or limited number of patients (Labefer, van
Spil, 2013). One of the likelyways to proceed is to investigate neoepitopes.
A collagen type II neoepitope C2C was developed for this purpose.
The aims of the study were to test: (i) the biomarker’s ability to dif-
ferentiate between patients with and without knee cartilage lesion, (ii)
if there is any correlation between urinary C2C output and clinical
status of patients with early knee osteoarthritis, (iii) preferable option
to express results (ng/mmol of creatinine or pg/ml of urine).
Material and methods: We investigated 180 knee OA patients (68
male, 112 female) aged 36-62 (mean 50) yrs. For 112 patients the pro-
gression of the knee OA during the past 3 years was available. Stand-
ardised radiographs of the tibiofemoral(TF) and patello[[Unsupported
Character – Codename -]]femoral(PF) joints were assessed. Radio-
graphic progression was deﬁned as: (i)presence of osteophytes and/or
joint space narrowing (JSN) in subjects with no previous radiographic
OA or (ii)increase in their grade.
Abstracts / Osteoarthritis and Cartilage 22 (2014) S57–S489 S71In a subset of 51 patients (25 male, 26 female, aged 32-56 yrs) the
degree of cartilage lesionwas assessed by an orthopedic surgeon on the
Outerbridge (0-IV) and VAS (0-10) scales in the medial femoral, medial
tibial and patellofemoral compartments. The clinical status of OA
patients was established by KOOS questionnaire (self-assessment) and
by four performance tests (up & go, raising from low chair, stairs-
stepping, 30 m walk).
The immunoassay used was C2C-HUSA (IBEX, Canada) that measures
the C2C neoepitope fragments present in human urine samples. For
statistical data analyses, T-test andSpearman’s rank correlationwereused.
Results: The uC2C values were signiﬁcantly higher for patients with
tibial or femoral lesion degree 2 or higher both at baseline and 3 yrs
after surgery (Fig. 1, B and 3 yrs).uC2C/crea at baseline and 3 yrs later 
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Fig. 1. Output of uC2C juxtaposed to different degrees of lesion in medial
tibial cartilageExcretion of u-C2C correlated positively with knee symptoms as well as
with limitations of everyday and demanding recreative (Sp/Rec) activ-
ities (Table 1).Table 1
Correlations between urinary C2C and results of KOOS questionnaire in female
patients
KOOS subscales, females uC2C expressed in
pg/ml urine
in ng/mmol creatinine
Knee symptoms 107 -0.267 0.005 -0.38 0.00005
knee pain 107 -0.272 0.005 -0.411 0.00001
limitations in ADL 107 -0.321 0.001 -0.464 0.0000005
limitations in Sp/Rec 105 -0.433 0.000004 -0.553 1E-09
Quality of life 107 -0.337 0.0004 -0.512 0.00000002Higher output of uC2C correlates with decline of the functional abilities
of lower limb. In both cases the correlations were stronger when uC2C
was expressed in ng/mmol creatinine (Tables 1, 2).Table 2
Correlations between urinary C2C and results of lower limb performance tests
Performance tests Valid
(N)
uC2C expressed in
pg/ml urine
uC2C expressed in
ng/mmol creatinine
Spearman
(R)
p-value Spearman
(R)
p-value
UP&GO, sec 107 0.304 0.001 0.415 0.000009
Up from low chair, cm 106 0.372 0.00008 0.525 0.000000008
Step up left leg, cm 107 -0.354 0.0001 -0.448 0.000001
Step up right leg, cm 107 -0.36 0.0001 -0.484 0.0000001
30 m walk, sec 107 0.238 0.014 0.405 0.00001Conclusions:
1. Signiﬁcantly higher excreation of uC2C is associated with grade 2þ
cartilage lesion in knee joint.
2. Highly signiﬁcant correlation appears between increased uC2C out-
put and decline in the clinical parameters of the lower limb.
3. The above correlations are stronger when uC2C is expressed in ng/
mmol creatinine.
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STROMAL CELL-DERIVED FACTOR-1 (SDF-1) VALIDATION USING
EQUINE SERUM, PLASMA, AND SYNOVIAL FLUID
M.P. Brown y, D.C. Dymock y, K.A. Merritt y, T.N. Trumble z. yUniv. of
Florida, Gainesville, FL, USA; zUniv. of Minnesota, St. Paul, MN, USA
Purpose: Stromal cell-derived factor-1 has been measured in syno-
vial ﬂuid (SF) and/or serum in humans and guinea pigs with OA. A
guinea pig study showed large increases in SF concentrations in
animals with primary OA and post-traumatic OA. Similarly, SF from
human OA patients had higher SDF-1 concentrations compared to
controls. Synovial ﬂuid SDF-1 concentrations, but not serum con-
centrations, in human patients with knee OA were shown to be
closely related with radiographic severity of OA. However, serum
concentrations were greater from OA patients when compared to
controls. Combined, these studies demonstrate that SDF-1 concen-
trations in serum or SF may distinguish OA patients from normal
controls. Based on these reports, it seems logical that the SDF-1
assay has the potential to help diagnose, predict, and monitor OA
changes in horses since the horse is a good translational model of
OA for biomarker evaluation. The purpose of this study was to val-
idate the use of the SDF-1 immunoassay in equine serum, plasma,
and SF.
Methods: To validate the SDF-1 immunoassay (Quantikine Human
SDF-1a Immunoassay, R&D Systems), plates from the same lot number
were used to minimize variation. Fresh serum, plasma, and SF were
collected aseptically from 6 normal Thoroughbred horses (6 geldings, 11
to 12 years of age) and samples for each ﬂuid were pooled together for
further analysis. Pooled serum, plasma, and SF samples were spiked
with a known amount of standard to create high (3000 pg/ml), medium
(1000 pg/ml), and low (200 pg/ml) quality control (QC) samples. All QC
samples within each ﬂuid were also pooled together to create a mixed
QC sample (mQC). Fresh pooled, QC, andmQC samples were analyzed at
neat, 1:2, 1:4, and 1:8 dilutions to determine precision, accuracy, line-
arity of dilution, parallelism, percent recovery, and stability of SDF-1
within each ﬂuid. Samples were analyzed in duplicate 3 times within a
plate (intra-assay variability) and across 3 plates (inter-assay varia-
bility). To analyze stability of SDF-1, fresh pooled samples were ana-
lyzed immediately after sample collection, as well as after 24 hours at
room temperature, after 24 hours at 4C, and after 1 to 4 freeze-thaw
cycles at -80C.
Results: Serum samples exhibited a mean intra-assay coefﬁcient of
variation (CV) of 7.5% and inter-assay CV of 10.1%. Plasma samples
exhibited a mean intra-assay CV of 7.8% and inter-assay CV of 13.5%.
Synovial ﬂuid samples exhibited a mean intra-assay CV of 7.6% and
inter-assay CV of 10.3%. The limit of detection for serum was 157.0 pg/
ml,161.2 pg/ml for plasma, and 128.5 pg/ml for SF. All diluted samples in
all ﬂuids demonstrated parallelism to the standard curve. Linearity was
demonstrated for serum and plasma at all dilutions, whereas SF dem-
onstrated linearity for 1:2 and 1:4 dilutions, but not for 1:8 dilutions
(recovery between 56 to 90% of neat samples). Recovery of spiked
samples in the region of the standard curve where all equine samples
congregated was 87% for serum, 95% for plasma, and 71% for SF. When
stored at room temperature, or at 4C for 24 hours, all ﬂuids demon-
strated minimal loss of stability. For serum and plasma, loss in stability
was< 10% of the ﬁrst freeze thaw out to 4 freeze thaw cycles, and for SF,
loss in stability was <10% of the ﬁrst freeze thaw out to 3 freeze thaw
cycles.
Conclusions: Serum and plasma SDF-1 concentrations are com-
parable to each other, whereas SF has more matrix effects at higher
dilutions. Overall, our results demonstrate that the SDF-1 immuno-
assay (Quantikine Human SDF-1a Immunoassay) is a reproducible
and valid assay for use with equine serum, plasma, and synovial
ﬂuid.
